ANAXOR Trademark

Trademark Overview


On Wednesday, July 27, 2022, a trademark application was filed for ANAXOR with the United States Patent and Trademark Office. The USPTO has given the ANAXOR trademark a serial number of 97523083. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 6, 2024. This trademark is owned by CTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd.. The ANAXOR trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hemoglobin; medicines for human purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; drugs for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the ...
anaxor

General Information


Serial Number97523083
Word MarkANAXOR
Filing DateWednesday, July 27, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hemoglobin; medicines for human purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; drugs for medical purposes for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCTTQ-Akeso (Shanghai) Biomed. Tech. Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBaoshan, Shanghai 201908
CN

Trademark Events


Event DateEvent Description
Saturday, July 30, 2022NEW APPLICATION ENTERED
Friday, May 12, 2023ASSIGNED TO EXAMINER
Friday, May 12, 2023SUSPENSION LETTER WRITTEN
Thursday, August 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 12, 2023LETTER OF SUSPENSION E-MAILED
Friday, May 12, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 5, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, January 18, 2024SUSPENSION INQUIRY WRITTEN
Thursday, January 18, 2024INQUIRY TO SUSPENSION E-MAILED
Thursday, January 18, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, February 7, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, February 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 6, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, May 6, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND